Oxygen and Exposure Kinetics as Factors Influencing the Cytotoxicity of Porfiromycin, a Mitomycin C Analogue, in Chinese Hamster Ovary Cells

Cancer Research

Volumn 48, Issue 20, 1988, Pages 5655-5659

  Marshall, Raymond S ^a   Rauth, A Michael ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; OXYGEN; PORFIROMYCIN;

ANIMAL CELL; CELL CULTURE; CHO CELL; DRUG CYTOTOXICITY; HAMSTER; HYPOXIA; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CELL LINE; CELL SURVIVAL; CRICETULUS; FEMALE; HAMSTERS; MITOMYCINS; OVARY; OXYGEN; PORFIROMYCIN; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0023741181     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kennedy, K. A., Teicher, B. A., Rockwell, S., and Sartorelli, A. C. The hypoxic tumor cell: A target for selective cancer chemotherapy. Biochem. Pharmacol., 29: 1-8, 1980.
2. Kennedy, K. A., Rockwell, S., and Sartorelli, A. C. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res., 40: 2356-2360, 1980.
3. Lin, A. J., Cosby, L. A., Shansky, C. W., and Sartorelli, A. C. Potential bioreductive alkylating agents. I. Benzoquinone derivatives. J. Med. Chem., 15: 1247-1252, 1972.
4. Marshall, R. S., and Rauth, A. M. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant. Cancer Res., 46: 2709-2713, 1986.
5. Keyes, S. R., Rockwell, S., and Sartorelli, A. C. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res., 45: 3642-3645, 1985.
6. Davison, A. J., Kettle, A. J., and Fatur, D. J. Mechanism of the inhibition of catatase by ascorbate. J. Biol. Chem., 261: 1193-1200, 1986.
7. Rockwell, S. Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro. Int. J. Cancer, 38: 229-235, 1986.
8. Gupta, V., and Costanzi, J. J. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells. Cancer Res., 47: 2407-2412, 1987.
9. Thompson, L. H., Rubin, J. S., Cleaver, J. E., Whitmore, G. F., and Brookman, K. A screening method for isolating DNA repair-deficient mutants of CHO cells. Somatic Cell Genet., 6: 391-405, 1980.
10. Marshall, R. S., Koch, C. J., and Rauth, A. M. Measurement of low levels of oxygen and their effect on respiration in cell suspensions maintained in an open system. Radial. Res., 108: 91-101, 1986.
11. Tomasz, M., Lipman, R., Chowdary, D., Pawlak, J., Verdine, G. L., and Nakanishi, K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (Wash. DC), 235: 1204-1208, 1987.
12. Meyn, R. E., Jenkins, S. F., and Thompson, L. H. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. Cancer Res., 42: 3106-3110, 1982.
13. Tannock, I. F. Oxygen diffusion and the distribution of cellular radiosensitivity in tumours. Br. J. Radiol., 45: 515-524, 1972.
14. Iyer, V. N., and Szybalski, W. A molecular mechanism of mitomycin action: Linking of complementary DNA strands. Proc. Natl. Acad. Sci. USA, 50: 355-362, 1963.
15. Fracasso, P. M., and Sartorelli, A. C. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells. Cancer Res., 46: 3939-3944, 1986.
16. Lown, J. W. The mechanism of action of quinone antibiotics. Mol. Cell Biochem., 55: 17-40, 1983.
17. Pritsos, C. A., and Sartorelli, A. C. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res., 46: 3528-3532, 1986.
18. Iyanagi, T., and Yamazaki, I. One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim. Biophys. Acta, 216: 282-294, 1970.
19. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sugar, S. G., and Sartorelli, A. C. Role of NAD(P)H: Cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44: 5638-5643, 1984.
20. Doll, D. C., Weiss, R. B., and Issell, B. F. Mitomycin: Ten years after approval for marketing. J. Clin. Oncol., 3: 276-286, 1985.
21. Erlichman, C., Rauth, A. M., Batistella, R., and Fine, S. Mitomycin C pharmacokinetics in patients with recurrent or metastatic colorectal carcinoma. Can. J. Physiol. Pharmacol., 65: 407-411, 1987.
22. Rockwell, S., Nierenburg, M., and Irvin, C. G. Effects of the mode of administration of mitomycin on tumor and marrow response and on the therapeutic ratio. Cancer Treat. Rep., 71: 927-934, 1987.
23. Djordjevic, B., and Kim, J. H. Different lethal effects of mitomycin C and actinomycin D during the division cycle of HeLa cells. J. Cell Biol., 38: 477-482, 1968.
24. Weissbach, A., and Lisio, A. Alkylation of nucleic acids by mitomycin C and porfiromycin. Biochemistry, 4: 196-200. 1965.
25. Chapman, J. D., Dugle, D. L., Reuvers, A. P., Meeker, B. E., and Borsa, J. Studies on the radiosensitizing effect of oxygen in Chinese hamster cells. Int. J. Radiat. Biol., 26: 383-389, 1974.
26. Rauth, A. M., and Mohindra, J. K. Selective toxicity of 5-(3, 3-dimethyl-1-triazeno)imidazole-4-carboxamide toward hypoxic mammalian cells. Cancer Res., 41: 4900-4905, 1981.